These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 23375981

  • 1. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
    Kristo I, Pitiriga V, Poulou A, Zarkotou O, Kimouli M, Pournaras S, Tsakris A.
    Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W, Park YJ, Park KG, Yu J.
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [Abstract] [Full Text] [Related]

  • 3. Molecular characterization of extended-spectrum beta-lactamases and its correlation with clinical laboratory standards institute interpretive criteria for disk diffusion susceptibility testing in enterobacteriaceae isolates in Thaialnd.
    Tangkoskul T, Tiengrim S, Onsomang S, Pati N, Aswapokee N, Thamlikitkul V, Chayakulkeeree M.
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1461-9. PubMed ID: 23413710
    [Abstract] [Full Text] [Related]

  • 4. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS, Lee WS, Bai KJ, Lam C, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR.
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [Abstract] [Full Text] [Related]

  • 5. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.
    Wang P, Hu F, Xiong Z, Ye X, Zhu D, Wang YF, Wang M.
    J Clin Microbiol; 2011 Sep; 49(9):3127-31. PubMed ID: 21752977
    [Abstract] [Full Text] [Related]

  • 7. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S, Garza-González E, Camacho-Ortiz A, González GM, Llaca-Díaz JM, Bosques F, Rositas F.
    Chemotherapy; 2012 Sep; 58(3):217-24. PubMed ID: 22814216
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, Kong H, Ni Y, Yu Y, Sun Z, Hu B, Huang W, Wang Y, Wu A, Feng X, Liao K, Shen D, Hu Z, Chu Y, Lu J, Su J, Gui B, Duan Q, Zhang S, Shao H.
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [Abstract] [Full Text] [Related]

  • 9. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H, Navarro RB, Yano H, Sombrero LT, Capeding MR, Lupisan SP, Olveda RM, Arai K, Kunishima H, Hirakata Y, Kaku M.
    Acta Trop; 2011 May; 120(1-2):140-5. PubMed ID: 21820398
    [Abstract] [Full Text] [Related]

  • 10. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
    Chia JH, Chu C, Su LH, Chiu CH, Kuo AJ, Sun CF, Wu TL.
    J Clin Microbiol; 2005 Sep; 43(9):4486-91. PubMed ID: 16145096
    [Abstract] [Full Text] [Related]

  • 11. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S, Gaind R, Ranjan R, Deb M.
    J Infect Dev Ctries; 2009 Nov 21; 4(1):24-9. PubMed ID: 20130375
    [Abstract] [Full Text] [Related]

  • 12. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S, Bloemberg GV, Giger J, Meyer V, Hombach M.
    J Antimicrob Chemother; 2012 Jan 21; 67(1):159-66. PubMed ID: 21972269
    [Abstract] [Full Text] [Related]

  • 13. Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.
    Kang CI, Cha MK, Kim SH, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.
    Int J Antimicrob Agents; 2014 May 21; 43(5):456-9. PubMed ID: 24690213
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
    Ko KS, Lee MY, Song JH, Lee H, Jung DS, Jung SI, Kim SW, Chang HH, Yeom JS, Kim YS, Ki HK, Chung DR, Kwon KT, Peck KR, Lee NY.
    Diagn Microbiol Infect Dis; 2008 Aug 21; 61(4):453-9. PubMed ID: 18482815
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL, Wang JT, Lauderdale TL, Chang SC.
    J Microbiol Immunol Infect; 2009 Aug 21; 42(4):310-6. PubMed ID: 19949754
    [Abstract] [Full Text] [Related]

  • 16. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA, Wu LT, Cheng KC, Ko WC, Chuang YC, Yu WL.
    J Microbiol Immunol Infect; 2010 Feb 21; 43(1):26-34. PubMed ID: 20434120
    [Abstract] [Full Text] [Related]

  • 17. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH.
    Antimicrob Agents Chemother; 2007 Nov 21; 51(11):4015-21. PubMed ID: 17724160
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
    Ko CS, Sung JY, Koo SH, Kwon GC, Shin SY, Park JW.
    Korean J Lab Med; 2007 Oct 21; 27(5):344-50. PubMed ID: 18094599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.